| 肺癌患者化疗前后血清SIL-2R、SCP活力检测的临床意义 |
| |
| 引用本文： | 周育洋,钱强.肺癌患者化疗前后血清SIL-2R、SCP活力检测的临床意义[J].放射免疫学杂志,2007,20(1):78-80. |
| |
| 作者姓名： | 周育洋 钱强 |
| |
| 作者单位： | 江苏省泗阳县人民医院,223700 |
| |
| 摘 要： | 目的:探讨了肺癌患者化疗前后血清SIL-2R和SCP活力的变化.方法:采用酶联免疫法(ELISA)和生化速率比色法测定了32例肺癌患者化疗前后血清SIL-2R和SCP活力的变化,并与30名正常健康人作比较.结果:化疗前血清SIL-2R和SCP活力均非常显著地高于正常人(P＜0.01),化疗后6个月复发者血清SIL-2R和SCP活力持续异常,未复发者SIL-2R和SCP活力水平恢复正常.结论:观察肺癌患者免疫功能的变化与患者的病情和预后密切相关.
|
| 关 键 词： | 肺癌 可溶性白细胞介素-2受体 铜蓝蛋白氧化酶 |
| 收稿时间： | 2006-09-30 |
| 修稿时间： | 2006年9月30日 |
Clinical Significance of Measurement of Changes of Serum SIL-2R and SCP Levels After Chemotherapy in Patients with Lung Cancers |
| |
| Zhou Yuyang,Qian Qiang.Clinical Significance of Measurement of Changes of Serum SIL-2R and SCP Levels After Chemotherapy in Patients with Lung Cancers[J].Journal of Radioimmanology,2007,20(1):78-80. |
| |
| Authors: | Zhou Yuyang Qian Qiang |
| |
| Abstract: | Objective To study the changes of serum SIL-2R and SCP levels after chemotherapy in patients with lung cancers.Methods Serum SIL-2R(with ELISA) and SCP(with biochemistry) levels were measured in 32 patients with lung cancers both before and after chemotherapy as well as in 30 controls.Results Before chemotherapy,in the patients,the serum SIL-2R and SCP levels were significantly higher than those in controls(P<0.01).Six months after chemotherapy the patients without recurrence(n=20) had their SIL-2R and SCP lvels returned to normal but in patients with recurrences(n=10) the levels were about the same as those before chemotherapy.Conclusion Determination of serum SIL-2R and SCP levels changes could reflect the immunostatus of the patients as well as the progress of diseases and could be of prognostic values. |
| |
| Keywords: | lung cancers soluble interleukin-2 receptor(IL-2R) ceruloplasminase |
| 本文献已被 CNKI 维普 万方数据 等数据库收录！ |
